ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

ClinicalTrials.gov ID: NCT06238778

Public ClinicalTrials.gov record NCT06238778. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Double-blind Trial Comparing HDV-Insulin Lispro Versus Insulin Lispro Alone in Adults With Type 1 Diabetes Receiving Insulin Degludec

Study identification

NCT ID
NCT06238778
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Diasome Pharmaceuticlas, Inc.
Industry
Enrollment
227 participants

Conditions and interventions

Interventions

  • HDV-Lispro Drug
  • Lispro Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2024
Primary completion
Sep 30, 2025
Completion
Nov 30, 2025
Last update posted
Aug 18, 2025

2024 – 2025

United States locations

U.S. sites
27
U.S. states
12
U.S. cities
26
Facility City State ZIP Site status
Marvel Clinical Research Huntington Beach California 92647
Pasadena Clinical Trials Pasadena California 91101
Diabetes Research Center Tustin California 92780
University of Colorado, Barbara Davis Center Denver Colorado 80045
East Coast Institute for Research Jacksonville Florida 32216
University of Miami Diabetes Research Institute Miami Florida 33136
Metabolic Research Institute West Palm Beach Florida 33401
Atlanta Diabetes Associates Atlanta Georgia 30318
East Coast Institute for Research Canton Georgia 30114
Physicians Research Associates, LLC Lawrenceville Georgia 30046
Endocrine Research Solutions, Inc. Roswell Georgia 30076
University of Chicago Kovler Diabetes Center Chicago Illinois 60637
Endeavor Health Skokie Illinois 60077
Indiana Medical Research Institute Merrillville Indiana 46410
SUNY Upstate Medical University Syracuse New York 13210
Asheville Clinical Research Asheville North Carolina 28803
UNC EnDO Clinical Research Unit Chapel Hill North Carolina 27514
Physician's East Greenville North Carolina 27834
University Hospitals Medical Center Cleveland Ohio 44106
Texas Diabetes & Endocrinology Austin Texas 78749
Tekton Research, LLC Irving Texas 75039
Tekton Research, LLC McKinney Texas 75069
Texas Diabetes % Endocrinology Round Rock Texas 78681
Clinical Trials of Texas San Antonio Texas 78229
Tekton Research, LLC San Antonio Texas 78251
Wasatch Clinical Research, LLC 310 Salt Lake City Utah 84107
Virginia Endocrinology Research Chesapeake Virginia 23321

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06238778, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06238778 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →